Showing results (301-310 of 481) with videos related to

Sort By:
Pageof 49
Journal of Biomedical Materials Research. Part B, Applied Biomaterials|May 16, 2017
Development of a SiYAlON glaze for improved osteoconductivity of implantable medical devicesRyan M Bock, Elia Marin, Alfredo Rondinella, et al.
Der Radiologe|December 5, 2000
[Quantitative recording of renal function with magnetic resonance tomography]S O Schoenberg, M Bock, S Aumann, et al.
American Journal of Physiology. Cell Physiology|March 18, 2026
A Long-Term Human Adipocyte Organoid Model Reveals Aging-Associated Responses to Intermittent HypoxiaYunzhou Dong, Jingjing Wang, Feifei Feng, et al.
Biology of Sport|November 21, 2018
Comparison of the effects of two antioxidant diets on oxidative stress markers in triathletesClaudia D Schneider, Patricia M Bock, Georgia F Becker, et al.
Journal of the Mechanical Behavior of Biomedical Materials|July 24, 2025
Hybrid-manufactured silicon nitride coated CFR-PEKK: A candidate biomaterial for trauma plate applications?Arjun Sharma, James A Smith, Michael A Kurtz, et al.
Diabetes Research and Clinical Practice|June 13, 2022
The impact of dietary, surgical, and pharmacological interventions on gut microbiota in individuals with diabetes mellitus: A systematic reviewPatricia M Bock, Andreza F Martins, Rafaela Ramalho, et al.
European Journal of Applied Physiology|April 19, 2020
Dietary nitrate does not acutely enhance skeletal muscle blood flow and vasodilation in the lower limbs of older adults during single-limb exerciseWilliam E Hughes, Nicholas T Kruse, Kenichi Ueda, et al.
European Radiology|January 1, 1996
Improved target volume definition in radiosurgery of arteriovenous malformations by stereotactic correlation of MRA, MRI, blood bolus tagging, and functional MRIL R Schad, M Bock, K Baudendistel, et al.
Investigative Radiology|November 26, 2002
Assessment of gadobenate dimeglumine for magnetic resonance angiography: phase I studiesM V Knopp, S O Schoenberg, C Rehm, et al.
Leukemia & Lymphoma|May 2, 2022
A phase 1b study of atezolizumab in combination with guadecitabine for the treatment of acute myeloid leukemiaThomas Prebet, Aaron D Goldberg, Joseph G Jurcic, et al.
Pageof 49